CYCLOPHOSPHAMIDE , RITUXIMAB , AB-101, FLUDARABINE
AB-101-05
Phase 2 small_molecule active
Quick answer
CYCLOPHOSPHAMIDE , RITUXIMAB , AB-101, FLUDARABINE for Systemic Sclerosis (SSc), Rheumatoid Arthritis (RA), Idiopathic Inflammatory Myopathies (IIMs), Sjögren’s Disease (SjD) is a Phase 2 program (small_molecule) at Artiva Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Artiva Biotherapeutics
- Indication
- Systemic Sclerosis (SSc), Rheumatoid Arthritis (RA), Idiopathic Inflammatory Myopathies (IIMs), Sjögren’s Disease (SjD)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active